Valproic Acid Tablets

Indicated to manage epilepsy to alleviate seizures.

Strengths: 250 · 500 · 750mg

Medicine details

Alternative names

Epilim; Depakote

Therapeutic class

Antiepileptic

Pharmacological class

Valproate

Known off-label uses

migraine prophylaxis

Contraindications

pregnancy; hepatic impairment; urea cycle disorders

Precautions and warnings

monitor liver function; avoid if history of pancreatitis; weight gain may occur

Minor side effects

nausea; tremor; dizziness

Moderate side effects

hair loss; weight gain; thrombocytopenia

Dosage forms

Gastro-resistant tablet; Prolonged-release tablet

Administration route

Oral use

Patient summary

Indicated to manage epilepsy to alleviate seizures.

Prescription status

POM

Manufacturer

Sanofi

Onset Time

1–2 weeks

Duration

12–24 hours

Storage instructions

Store below 25°C.

Drug interactions

Phenobarbital; Warfarin; Aspirin

Age restrictions

Careful monitoring in children.

Serious side effects

hepatotoxicity — requires immediate medical attention; pancreatitis — requires immediate medical attention

Mechanism of action

Valproic acid dissociates to the valproate ion in the gastrointestinal tract. It increases gamma-aminobutyric acid (GABA) levels in the brain, thereby increasing inhibitory activity and stabilising nerve cell excitability to prevent seizures.

Pregnancy and breastfeeding

Pregnancy: Contraindicated; causes major birth defects. Breastfeeding: Limited use; discuss with specialist.

Valproic Acid Tablets

Indicated to manage epilepsy to alleviate seizures.

Editorial Notes

  • Active ingredient(s): Valproic Acid
  • Listed indication(s): Epilepsy, Bipolar Disorder

Usually available as

  • 30 tablets - 250 mg1322-250-mg-15876
  • 30 tablets - 500 mg1322-500-mg-15879
  • 30 tablets - 750 mg1322-750-mg-15881